pal functional hyperemia mediated by NMDA receptor/NO signaling in rats during mild exercise. J Appl Physiol 112: 197-203, 2012. First published September 22, 2011 doi:10.1152 doi:10. /japplphysiol.00763.2011rent studies have demonstrated that exercise increases regional cerebral blood flow (rCBF), an index of neuronal activity. However, neuronal regulation of the increased rCBF in the brain parenchyma is poorly understood. We developed a running model with rats for monitoring hippocampal cerebral blood flow (Hip-CBF) and found that mild treadmill running increases Hip-CBF in a tetrodotoxin-dependent manner, suggesting that functional hyperemia, an increase in rCBF in response to neuronal activation, occurs in the running rat's hippocampus (Nishijima T and Soya H. Neurosci Res 54: 186-191, 2006). To further support our hypothesis, it was important to discover the neurogenic pathways behind the increase in Hip-CBF that occurred during running. Here, we examine the possible role of N-methyl-D-aspartate (NMDA) receptor/nitric oxide (NO) signaling and group I metabotropic glutamate receptors in mediating the Hip-CBF increase. Hip-CBF during running was measured by laser-Doppler flowmetry. Intrahippocampal drug administration was performed by microdialysis. Mild treadmill running (10 m/min) increased Hip-CBF, which was remarkably attenuated by either NMDA receptor antagonists (1 mM MK-801) or NO synthase inhibitors (2 mM N G -nitro-L-arginine methyl ester). However, group I metabotropic glutamate receptor antagonists {1 mM 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester ϩ 1 mM 2-methyl-6-(phenylethynyl)pyridine hydrochloride} augmented the running-induced Hip-CBF increase. We also found that rCBF in the olfactory bulb was unchanged with running. These results strongly suggest that Hip-CBF during mild exercise is regulated locally under hippocampal neuronal activity, mediated mainly through NMDA receptor/NO signaling. Collectively, these results, together with our previous findings, support our hypothesis that mild exercise elicits neuronal activation, which then triggers functional hyperemia in the rat hippocampus.
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cerebral blood flow; hippocampus; laser-Doppler flowmetry; microdialysis; running REGULATION OF CEREBRAL CIRCULATION is critical for maintaining brain function during exercise (37, 40, 42) . In the brain parenchyma, neuronal activation triggers an increase in regional cerebral blood flow (rCBF) to meet increased metabolic demands. This tightly regulated phenomenon is termed "neurovascular coupling" (16, 43) . Based on this theory, animal studies examining the distribution of rCBF as an index of neuronal activity during exercise have demonstrated increases in rCBF in the brain loci associated with motor execution and control (11, 17) . These findings are supported by several human studies (20, 25) . Although the importance of the vasodilative effect of increased neuronal activity during exercise is well known (37, 40, 42) , the molecular mechanisms underlying the increase in rCBF are still poorly understood.
To address this issue, we have developed an experimental model for monitoring rCBF in rats during mild treadmill running using laser-Doppler flowmetry (LDF) (35) . LDF has the advantage of monitoring changes in rCBF in real-time, while the rat continues to run on the treadmill. In addition, we have demonstrated that local drug infusion via microdialysis into the loci where rCBF is being monitored is useful in examining the molecular mechanisms behind enhanced rCBF (35, 36) .
The hippocampus, a key structure for learning and memory, has been targeted because considerable evidence has accumulated demonstrating that exercise improves not only neuronal (9, 12, 45, 47, 48) , but also cerebrovascular, plasticity in the hippocampus of rodents (23, 24, 26) . However, neurophysiological responses, including synaptic activity and blood flow change in the hippocampus, are poorly understood during exercise. To further clarify how exercise exerts its beneficial effects on the hippocampus, it would be valuable to understand neurovascular responses and their regulation during exercise. Among hippocampal subregions, we have chosen CA1 area. Since this region is selectively vulnerable to ischemia (41) , it would be also important to know whether the CA1 area of the hippocampus suffers ischemia during exercise or not. In our previous study, we showed that mild treadmill running increased hippocampal cerebral blood flow (Hip-CBF) in a tetrodotoxin-dependent manner (35) . This finding suggests that mild exercise activates hippocampal neurons and subsequently causes functional hyperemia in the rat hippocampus, although further study examining the neurogenic mechanisms of Hip-CBF regulation is still needed.
Among numerous mediators involved in neurovascular regulation (16) , activation of N-methyl-D-aspartate (NMDA) receptors and subsequent production of nitric oxide (NO) has been shown to be one of the major signal cascades in previous studies using anesthetized animals and/or brain slice preparations (1, 6, 13, 14, 21, 31, 39) . In addition, group I metabotropic glutamate receptors (mGluRs) on astrocytes also mediate the coupling of synaptic activity to local vasodilation (2, 16, 51) . However, it is still uncertain whether these mediators are also involved in neurovascular regulation in exercising animals. To further support our working hypothesis that mild exercise elicits hippocampal neuronal activity, which would, in turn, be a prerequisite in regulating Hip-CBF during exercise, we examined whether NMDA receptor/NO signaling and group I mGluRs together mediate exercise-induced functional hyperemia in the rat hippocampus.
EXPERIMENTAL PROCEDURES
Animals. Adult male Wistar rats (SLC, Shizuoka, Japan), weighing 270 -320 g, were housed under standard lighting conditions (light from 0700 to 1900) and temperatures (22-24°C) . Food and water were available ad libitum. All rats were weighed and handled daily throughout the course of the study. All procedures were performed in accordance with, and approved by, the Institutional Guidelines for Animal Care at the University of Tsukuba, which conform to the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.
Surgery. Rats were anesthetized with pentobarbital sodium (50 mg/kg ip) and fixed to a stereotaxic frame (SR-5, Narishige, Tokyo, Japan) in the prone position. Two guide cannulas, one for LDF (outer diameter 0.8 mm, Omegawave, Tokyo, Japan) and the other for microdialysis (outer diameter 1.0 mm, ALS, Tokyo, Japan), were implanted into the left dorsal hippocampal CA1 region as described previously (35, 36) (Fig. 1) . The stereotaxic coordinate for the LDF guide cannula was as follows: antero-posterior (AP) Ϫ3.5 mm, lateral (L) 2.0 mm from the bregma, and ventral (V) Ϫ2.0 mm from the dura; for the microdialysis guide cannula it is AP Ϫ3.5 mm, L 3.5 mm from the bregma, and V Ϫ1.7 mm from the dura at an angle of 20° (38) . These were fixed to the skull with three anchor screws using dental cement. After surgery, the rats were housed individually and allowed to recover for 2 days. Twenty-four hours before the experiment, a microdialysis probe (MAB6, membrane length 2.0 mm, outer diameter of membrane 0.5 mm, ALS, Tokyo, Japan) was inserted through the guide cannula.
Measurement of Hip-CBF. Hip-CBF was measured using a laserDoppler flowmeter (FLO-C1, Omegawave, Tokyo, Japan). A flexible optical fiber covered with polyethylene tubing was inserted through the guide cannula, without protruding from the tip of the guide, and fixed tightly with a locknut before each experiment. The time constant of the laser-Doppler flowmeter was 0.01 s. The LDF signals were amplified using a PowerLab (ADInstruments, NSW, Australia) and recorded on a Macintosh computer.
Drugs. Artificial cerebrospinal fluid (aCSF) consists of 124 mM NaCl, 25.7 mM NaHCO 3, 3.3 mM KCl, 1.3 mM KH2PO4, 2.4 mM MgSO 4, and 2.0 mM CaCl2 (pH 7.4). NMDA was purchased from Nacalai Tesque (Kyoto, Japan). The following drugs were purchased from Tocris (Ellisville, MO):
chrome n-1a-carboxylate ethyl ester (CPCCOEt; mGluR1 antagonist); and 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP; mGluR5 antagonist). Since all of the drugs were administered via microdialysis, the doses used in this study were based on previous microdialysis studies (3, 10) .
Study 1: Systemic effects of intrahippocampal drug treatment. First, we examined whether local intrahippocampal infusion of either MK-801 or L-NAME by microdialysis had any effects on mean arterial pressure (MAP) and arterial blood gas tensions to rule out the influence of intrahippocampal drug infusions on these arterial parameters, which regulate rCBF systemically. Rats were anesthetized with urethane (1.1 g/kg ip), and the anesthesia was maintained with intermittent intraperitoneal injections of urethane (ϳ0.1 g·kg Ϫ1 ·h Ϫ1 ). The trachea was cannulated and ventilated with ambient air. The right carotid artery was cannulated with PE-50 polyethylene tubing for monitoring MAP and sampling arterial blood. The rats were stereotaxically fixed in the prone position, and body temperature (measured rectally) was maintained at ϳ37.0°C by means of a heating pad (BWT-100, BRC, Nagoya, Japan). After stabilization for 30 min, aCSF was infused for ϳ60 min, then MK-801 (1 mM, n ϭ 4) or L-NAME (2 mM, n ϭ 4) dissolved in aCSF was infused for 60 min using a microinjection pump (flow rate: 2.5 l/min, CMA102, CMA/ Microdialysis, Stockholm, Sweden). Arterial blood samples were collected before and after each drug treatment, and pH, arterial PCO2 (PaCO 2 ), and arterial PO2 (PaO 2 ) were measured immediately using an automated blood-gas analyzer (248, Bayer).
Study 2: Effects of MK-801 or L-NAME on Hip-CBF during mild treadmill running. We examined whether NMDA receptor and subsequent production of NO mediate the increase in Hip-CBF with mild treadmill running. The details of how to measure Hip-CBF in the treadmill-running rats have been described previously (35) . Briefly, before the surgical implantation of the guide cannulas, as described above, all of the rats were habituated to the treadmill apparatus (KN-73, Natsume, Tokyo, Japan) through mild treadmill running for 30 -60 min/day for 5 days. The running speed and duration were gradually increased, and, by the final training session, the rats were able to run at a speed of 10 m/min for the first 30 min, then 15 m/min for the next 30 min without any electrical stimulation to encourage them to start running.
After the surgery described above, the rats were randomly assigned to three groups: 1) MK-801 infusion (n ϭ 7); 2) L-NAME infusion (n ϭ 5); and 3) aCSF infusion (n ϭ 6). Rats were connected to the laser-Doppler flowmeter with a flexible optical fiber, placed in a polycarbonate cage, and stabilized for ϳ1 h with an aCSF infusion via microdialysis. The infusion was then paused, and the rats were transferred to the treadmill and stabilized again for 15 min. After these procedures, the rats were subjected to running for 80 min at a speed of 10 m/min. This speed is considered mild because blood lactate does not accumulate throughout the session at this duration and speed (35) . MK-801 (1 mM) or L-NAME (2 mM) or aCSF was continuously infused from 20 min after the start of running. Both the optical fiber and polyethylene tubing connected to the implanted microdialysis probe were passed through a slit in the ceiling of the treadmill.
One day before the experiment, a familiarization trial that consisted of a 1-h stabilization period in the home cage, 20-min stabilization on the treadmill, and 20-min treadmill running at a speed of 10 m/min was performed. Familiarization with treadmill running with a cable connection effectively reduces mechanical artifacts produced by jerky movements (35) .
Study 3: Effect of group I mGluR antagonists on Hip-CBF during mild treadmill running.
We then examined whether group I mGluRs mediate the increase in Hip-CBF with mild treadmill running. The entire procedure was the same as study 2. The group I mGluR antagonists [1 mM CPCCOEt ϩ 1 mM MPEP dissolved in aCSF containing 4% DMSO (CϩM), n ϭ 8] or vehicle (aCSF containing 4% DMSO, n ϭ 7) were continuously infused via microdialysis from 20 min after the start of running.
Study 4: Olfactory-CBF during mild treadmill running. Finally, to support the finding that the increase in Hip-CBF with running is due to regional neurogenic response, we looked for any brain regions where rCBF did not change with running. Since Delp et al. (11) demonstrated by using the microsphere technique that olfactory CBF (Olf-CBF) does not change with treadmill running in miniature swine, we measured Olf-CBF during mild treadmill running in rats. A guide cannula for LDF was surgically placed with the tip of the cannula touching on the olfactory bulb (AP ϩ6.5 mm from bregma, L 1.0 mm). A microdialysis probe was not inserted. The procedure to measure CBF during running was also followed as described above.
Data and statistical analysis. After each experiment was completed, the placement of the cannulas was confirmed by histology (Fig. 1) . If the placements were incorrect, the data were omitted. LDF data were averaged at 5-min intervals and represented as relative changes vs. the baseline, which was a steady state during resting on the treadmill. All data are expressed as means Ϯ SE. The Hip-CBF data in studies 2 and 3 were analyzed by two-way repeated-measures ANOVA with post hoc tests at individual time points (GraphPad Prizm).
RESULTS

Study 1.
Arterial blood parameters before and after intrahippocampal infusion of MK-801 (1 mM) or L-NAME (2 mM) are presented in Table 1 . MAP, pH, Pa CO 2 , and Pa O 2 before and after each drug infusion were within normal physiological ranges. There were no statistically significant differences for all parameters before and after the drug treatment (paired t-test), suggesting that intrahippocampal infusion of those agents has no effect on the arterial parameters regulating CBF systemically. These results strengthen the validity of local drug treatment via microdialysis, which enables us to examine the mechanisms underlying neuronal regulation of functional hyperemia without systemic alteration.
Study 2. The effect of MK-801 (1 mM) and L-NAME (2 mM) on Hip-CBF during mild treadmill running is shown in Fig. 2 . Figure 2A shows typical raw data from laser-Doppler recordings of Hip-CBF during treadmill running at a speed of 10 m/min. In all groups, Hip-CBF increased with mild treadmill running as in our previous study (35) . In the aCSFinfusion group, Hip-CBF maintained a consistent increase throughout the session of treadmill running. In contrast, the Values are means Ϯ SE; n, no. of rats. MAP, mean arterial pressure; PaCO 2 , arterial PCO2; PaO 2 , arterial PO2. MK-801 (1 mM) or N G -nitro-L-arginine methyl ester (L-NAME; 2 mM) was infused into the hippocampus via microdialysis for 60 min. increase in Hip-CBF was suppressed with both MK-801 and L-NAME infusion. The overall significance of the interaction (time ϫ treatment) [F(34, 255) ϭ 3.79, P Ͻ 0.0001] was observed by two-way repeated-measures ANOVA. Tukey's post hoc tests at individual time points indicated significant differences between MK-801 and aCSF (60 -80 min, P Ͻ 0.05), and L-NAME and aCSF (35-80 min, P Ͻ 0.05).
Infusion of MK-801 or L-NAME evoked no behavioral changes in the running rats, and the rats easily maintained a consistent running speed throughout a session of treadmill running. In a separate experiment, we examined whether these inhibitors affect resting Hip-CBF level and found that neither MK-801 nor L-NAME infusion altered resting Hip-CBF level at free-moving condition (data not shown).
Study 3. The effect of group I mGluR inhibitors (CϩM) on Hip-CBF during mild treadmill running is shown in Fig. 3 . Figure 3A shows typical raw data from laser-Doppler recordings of Hip-CBF during treadmill running. Infusion of vehicle (aCSF containing 4% DMSO) did not affect the Hip-CBF during running. Unexpectedly, infusion of CϩM increased the Hip-CBF during running. However, the effect of interaction (time ϫ treatment) analyzed by two-way repeated-measures ANOVA did not reach statistical significance [F(17, 187) ϭ 1.45, P ϭ 0.116], presumably due to the complex pattern of Hip-CBF changes in CϩM infusion group. Because the effect of interaction was close to marginal, we performed unpaired t-tests as post hoc at individual time points and found significant differences between groups (45-55 min, P Ͻ 0.05).
Infusion of CϩM evoked no behavioral changes in the running rats. We also confirmed that infusion of CϩM caused no change in resting Hip-CBF level at free-moving condition (data not shown).
Study 4. Figure 4A shows typical raw data from laser-Doppler recordings of Olf-CBF during treadmill running, which demonstrated that Olf-CBF does not change with mild treadmill running. To confirm whether Olf-CBF responds to odor stimuli, ethanol-(70%) immersed cotton was placed in front of the rat after each running experiment. When the rat sniffed the ethanol, Olf-CBF increased instantaneously (Fig. 4B) .
DISCUSSION
To further investigate the neuronal regulation of Hip-CBF during exercise, the present study examined whether the Hip-CBF changes during mild treadmill running are under the control of NMDA receptor/NO signaling and group I mGluRs. We employed our unique running model with rats that enables real-time monitoring of Hip-CBF by LDF, and local drug administration by microdialysis. With this model, we have previously demonstrated that treadmill running increases Hip-CBF in a TTX-dependent manner (35) . The present study further revealed that the increase in Hip-CBF is remarkably suppressed by the infusion of either MK-801 or L-NAME, but augmented by group I mGluR antagonists (CϩM). These results demonstrate that exercise-induced functional hyperemia is mainly mediated through NMDA receptor/NO signaling in the rat hippocampus, which strongly supports our hypothesis that hippocampal neuronal activity elicited by exercise plays a crucial role in regulating the Hip-CBF increase.
For monitoring rCBF changes in the brain parenchyma of rodents, LDF is ideal because of its high spatial resolution, as the measuring volume is ϳ1 mm 3 from the tip of the probe (4, 15, 19, 21) . Furthermore, LDF enables continuous and realtime monitoring of rCBF, even in moving rodents (18, 30, 32, 35) . By using LDF, Nakajima et al. (32) reported that treadmill walking (2.4 m/min) increased Hip-CBF in rats, and the in- crease was partially suppressed by an intravenous injection of mecamylamine, a nicotinic acetylcholine receptor antagonist. However, the intravenous injection altered MAP, which may have resulted in biased results. Hence, we applied the microdialysis technique to deliver drugs directly into the loci where Hip-CBF is monitored. Kaiser and During (21) reported that hippocampal neuronal activation elicited by NMDA infusion via microdialysis induced no changes in MAP and arterial blood gases in anesthetized rats. As shown in Table 1 , we also confirm that neither MK-801 nor L-NAME induce any changes in arterial blood parameters, suggesting intrahippocampal drug treatment, which can affect neuronal activity and neurovascular regulation, causes less systemic alteration. Taken together, these methodological considerations enable us to examine the regional neurogenic regulation of Hip-CBF in the running rat.
Both MK-801 and L-NAME are known to inhibit neurovascular coupling (1, 6, 13, 31, 50) . Also, in this study, intrahippocampal infusion of both MK-801 and L-NAME almost completely attenuated the increase in Hip-CBF with running. The Hip-CBF levels after the 60 min of MK-801 and L-NAME treatment was 105.1 Ϯ 5.0 and 104.0 Ϯ 9.6% vs. the baseline, respectively. These results suggest that activation of NMDA receptor/NO signal cascade is a potent mediator in functional hyperemia elicited by mild treadmill running. So far, many studies have demonstrated the pivotal role of NMDA receptor/NO signaling in anesthetized animals and/or brain slice preparations; our present results provide the first evidence demonstrating that this signal cascade is also involved in the regulation of neurovascular coupling in a conscious physiological state, such as running.
Unexpectedly, the infusion of group I mGluR antagonists (CϩM) failed to suppress the increase in Hip-CBF. In fact, CϩM elevated the level of Hip-CBF during treadmill running. Contrary to this finding, Zonta et al. (51) demonstrated that astrocytes are involved in neurovascular regulation through activation of their group I mGluRs (51) . However, it would be noteworthy that they used cortical slices as an experimental model. Therefore, the discrepancy of the results might be due to the methodological differences, such as targeted brain region (hippocampus or cortex) and experimental model (running rat or brain slice). Furthermore, it would be also important to note multiple functions of mGluRs, depending on their localization. Group I mGluRs are localized not only on astrocytes but also on postsynaptic membrane in the rat hippocampus (27) . In the CA1 area of the hippocampus, where we monitored Hip-CBF, the postsynaptic group I mGluRs are involved in inhibition of synaptic excitability through a retrograde signaling via the endogenous cannabinoid (28, 29, 49) . Our results may suggest that this inhibitory function of mGluRs is more dominant rather than neurovascular regulation in the hippocampus during running, i.e., the inhibition of group I mGluRs by CϩM might enhance hippocampal neuronal activity during treadmill running, which, in turn, augmented the Hip-CBF increase.
Exercise, depending on its intensity and duration, can elicit changes in arterial blood gases and MAP, which are known to alter rCBF. In our previous study, we also found in our model that mild treadmill running slightly increased MAP (from 100 mmHg at basal to 112 mmHg at 30 min after running), decreased Pa CO 2 (from 34 to 31 Torr), and increased Pa O 2 (from 95 to 99 Torr), respectively (35) . Therefore, it may be possible that the increase in Hip-CBF during treadmill running is merely a global CBF alteration elicited by the increased MAP, whereas, in this study, we demonstrated that Olf-CBF was unchanged with mild treadmill running. First, this result refutes the possibility that the increase in Hip-CBF is a nonspecific mechanical artifact. More importantly, the region-dependent changes in rCBF strongly support our finding that Hip-CBF during running is regulated by local neuronal activity in the hippocampus. In a separate set of experiments, we also confirmed that both Hip-CBF and Olf-CBF increased similarly in response to hypercapnia in urethane-anesthetized rats (data not shown). These results clearly demonstrate not only regiondependent but also stimulus-dependent regulation of rCBF.
Physical exercise can improve both neuronal and cerebrovascular plasticity in the hippocampus, although the underlying mechanisms remain uncertain. Previous literature demonstrated that brain-derived neurotrophic factor (BDNF) is one of the key molecules mediating the benefits of exercise on the hippocampus (8, 9) . Here it must be noted that BDNF is an activity-dependent gene, and BDNF mRNA expression is regulated through NMDA receptor activation (46) . Furthermore, Kitamura et al. (22) directly demonstrated that activation of NMDA receptor in the hippocampus is necessary for the exercise-induced BDNF production with mice lacking the NMDA receptor-ε1 subunit (22) . Therefore, hippocampal neuronal activation evoked by physical exercise has been regarded as a basis for promoting hippocampal plasticity (7, 22) , despite the lack of direct evidence. Our present results clearly demonstrate that hippocampal neuronal activity is increased during mild treadmill running. Our neurophysiological evidence will help to further the understanding of the underlying mechanisms of how exercise exerts its beneficial effects on the hippocampus.
Serum insulin-like growth factor I (IGF-I) is another candidate mediating the benefits of exercise on the hippocampus (5, 26) . We have recently demonstrated that neurovascular coupling triggers an uptake of serum IGF-I into the brain across the blood-brain barrier (34) . Therefore, exercise might facilitate IGF-I uptake into the hippocampus through neurovascular coupling, which, in turn, confers the neuroprotective effects of IGF-I on hippocampal plasticity.
It would be noteworthy that the rats in our study were subjected to running at a mild intensity. Because exercise can be a physiological stress if exercise intensity exceeds the lactate threshold (44) , intense exercise inhibits positive effects of exercise on the hippocampus (33) . The previous literature, together with our finding that mild exercise increased hippocampal neuronal activity, leads us to hypothesize that mild intensity of exercise would be preferable to gain benefits of exercise, such as increase in BDNF expression on the hippocampus, although further study is required.
In summary, the present study shows that mild treadmill running increases Hip-CBF where NMDA receptor/NO signaling works as mediators of neurogenic vasodilation in the rat hippocampus. This finding strengthens our previous finding that mild exercise causes functional hyperemia in the rat hippocampus. Although the involvement of group I mGluR in neurovascular regulation has still to be determined, our results imply that group I mGluRs might rather have an inhibitory role in synaptic neurotransmission during exercise. Collectively, our results provide evidence supporting our hypothesis that neuronal activity and neurogenic mediators are functionally involved in the regulation of Hip-CBF during mild exercise.
